logo

PGIM India Healthcare Fund - Regular Plan - Growth Option

Category: Equity: Sectoral-Pharma and Healthcare Launch Date: 19-11-2024
AUM:

111.64 Cr

Expense Ratio

2.58%

Benchmark

BSE Healthcare TRI

ISIN

INF663L01Z52

Minimum Investment

5000.0

Minimum Topup

1000.0

Minimum SIP Amount

1000

Fund Manager

Anandha Padmanabhan Anjeneyan, Utsav Mehta, Vivek Sharma, Puneet Pal

Fund Performance 1Y (%) 3Y (%) 5Y (%)
PGIM India Healthcare Fund - Regular Plan - Growth Option 21.89 - -
Benchmark - - -
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%

Overview

NAV
12.14
Last change
-0.03 (-0.2471%)
Fund Size (AUM)
₹ 111.64 Cr
Performance
12.42% (Inception)

Asset Allocation

Equity

Debt

Others

Nav Movement

Investment Objective

The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there is no assurance that the investment objective of the scheme will be achieved. The Scheme does not guarantee/ indicate any returns.

Fund Manager
Anandha Padmanabhan Anjeneyan, Utsav Mehta, Vivek Sharma, Puneet Pal
Riskometer
Very High

Top 10 Holdings

Company Holdings (%)
SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- 10.86
DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- 9.14
MAX HEALTHCARE INSTITUTE LIMITED EQ 6.52
ASTER DM HEALTHCARE LIMITED EQ 6.41
JB Chemicals & Pharmaceuticals Limited 6.4
AJANTA PHARMA LIMITED EQ NEW FV RS. 2/- 5.56
MANKIND PHARMA LIMITED EQ NEW FV RE. 1/- 5.19
Krishna Institute Of Medical Sciences Limited 4.12
Rubicon Research Ltd. 3.99
Clearing Corporation of IndiLtd. 3.19

Sector Allocation

Sector Holdings (%)
Healthcare 91.64
Chemicals 3.09
Financial Services 1.03
Consumer Services 0.67
Information Technology 0.47